The XOSPATA QUICK START+ Program provides a one-time, 7-day supply of XOSPATA® (gilteritinib) at no cost to eligible patients who experience an insurance-related delay.

  • To be eligible for the QUICK START+ Program, patients must:
    • Have prescription drug insurance,
    • Be new to XOSPATA therapy,
    • Have been prescribed XOSPATA for an FDA-approved indication, AND
    • Have experienced an insurance-related access delay
  • Offers overnight shipping directly to the patient

XOSPATA Support Solutions is a component of Astellas Pharma Support SolutionsSM.

QUICK START+® is a registered trademark of Astellas US LLC.

XOSPATA® is a registered trademark of Astellas Pharma Inc.